Recurrent or Progressive Endometrial Cancer
Oncology·MeSH: Recurrence
Prevalence
58.0 / 100K
Incidence
28.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Recurrent or Progressive Endometrial Cancer?
There are 1 clinical trial targeting Recurrent or Progressive Endometrial Cancer tracked by BioSniper.
What is the prevalence of Recurrent or Progressive Endometrial Cancer?
The estimated prevalence of Recurrent or Progressive Endometrial Cancer is approximately 58.0 per 100,000 population.
Deep-dive into Recurrent or Progressive Endometrial Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis